Featured Articles
-
Optimizing Performance For De-Risked Lentiviral Vector Production
6/12/2024
Discover a de-risked, reproducible, and scalable platform for efficient GMP manufacturing of lentiviral vectors that maximizes titers and enriches recovery through upstream and downstream optimization.
-
Fab Fragment Development And Manufacturing For Clinical Trials
6/12/2024
Explore the outcomes of implementing an accelerated approach to process development and manufacturing for a project that was crucial for the future of Acticor Biotech and its therapeutic candidate.
-
Optimizing mRNA For Success: A Guide To Enhanced Stability, Delivery, And Efficacy
6/11/2024
RNA offers exciting potential for vaccines, gene therapies, and personalized medicine, but challenges related to stability, delivery, and manufacturing persist.
-
Sterility Testing Of Products With Antimicrobial Properties
6/4/2024
Drugs formulated with antibiotics, preservatives, or other chemicals may inhibit microbial viability and growth. Learn more about three golden rules to be effective against antimicrobial effects.
-
Sterility Testing Of Products To Be Diluted In Isopropyl Myristate
6/4/2024
Discover one possible test set-up to dilute a product in isopropyl myristate, filter it, and rinse the membrane to eliminate residues that may inhibit microbial growth.
-
Sterility Method Development And Suitability Testing
6/4/2024
Does each formulation and product type require method development? Explore a matrix approach to method development and suitability testing for the compounding industry.
-
The Evolution Of Antibody-Drug Manufacturing
6/3/2024
Explore how ADC chemistry and manufacturing have evolved, the challenges this dynamic growth has created, and how CDMOs are adapting to these changes to meet customer needs, now and in the future.
-
Overcoming The Solubility Challenges Of Antibody-Drug Conjugates
6/3/2024
Discover a chito-oligosaccharide that significantly improves the solubility of antibody-drug conjugates (ADCs) when included in the linker-payload construct.
-
Efficacy Screening Of Antibody-Drug-Conjugates By Surface Plasmon Resonance
6/3/2024
Rapid screening of ADC affinity using surface plasmon resonance provides preliminary efficacy data in comparing antigen binding affinity with selected linkers and payloads to the non-conjugated antibody.
-
Establishing Commercial Manufacturing Services For ADCs
6/3/2024
Explore how one organization built upon 15+ years of experience and an extensive knowledge base of biologics manufacturing to establish commercial-scale ADC manufacturing capabilities.